510(k) Report

510(k) · Cleared

Cleared

Insyte, Angiocath, Insyte Autoguard, Angiocath Autoguard, Autoguard Pro, Intima, and Saf-T-Intima Intravascular Cathete

K013800510(k) TraditionalCleared Dec 21, 200136-day reviewClass II21 CFR 880.5200

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Becton Dickinson Infusion Therapy Systems, Inc. · FOZ Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days

Cleared on Dec 21, 2001 after a 36-day review. The FDA summary names its predicate without a number. 35 later devices descend from it.

Decided
Dec 21, 2001
Review
36 days
Class
Class II
Product code
FOZ
Recalls
None
Predicates
0

35 later devices descend from it, 7 citing it directly.

Descendants, by year cleared 2025: 5 descendants cleared2022: 2 descendants cleared2009: 2 descendants cleared2020: 4 descendants cleared2015: 3 descendants cleared2011: 1 descendant cleared2012: 3 descendants cleared2014: 2 descendants cleared2017: 1 descendant cleared2023: 1 descendant cleared2013: 1 descendant cleared2026: 2 descendants cleared2019: 3 descendants cleared2016: 3 descendants cleared2018: 1 descendant cleared2024: 1 descendant cleared200020052010201520202025
  1. This deviceK013800 Insyte, Angiocath, Insyte Autoguard, Angiocath Autoguard, Autoguard…Becton Dickinson Infusion Therapy Systems, Inc. · 2001
  2. Descendant · cites it directly · 28 of its ownK081953 Supercath 5Togo Medikit Co., Ltd. · 2009
  3. Descendant · cites it directly · 27 of its ownK093546 Supercath 5 Model SP120-XX-XX, SP125-XX-XXTogo Medikit Co., Ltd. · 2009
  4. Descendant · cites it directly · 21 of its ownK110443 BD Insyte Autoguard BCBecton, Dickinson & CO · 2011
  5. Descendant · 2 generations on · 7 of its ownK140504 Accucath BC Intravascular Catheter SystemVascular Pathways, Inc. · 2014
  6. Descendant · 3 generations on · 5 of its ownK153298 AccuCath Intravascular CatheterC.R. Bard, Inc. · 2015

Showing 5 of 35 descendants. See all descendants

Descendants cleared per year

2009: 22011: 12012: 32013: 12014: 22015: 32016: 32017: 12018: 12019: 32020: 42022: 22023: 12024: 12025: 52026: 2
2009high 5 (2025) · low 0 (2010)2026

Most influential descendants

Showing 5 of 35 · See all
  • K081953Supercath 5Togo Medikit Co., Ltd. · 2009 · cites it directly28descendants
  • K093546Supercath 5 Model SP120-XX-XX, SP125-XX-XXTogo Medikit Co., Ltd. · 2009 · cites it directly27descendants
  • K110443BD Insyte Autoguard BCBecton, Dickinson & CO · 2011 · cites it directly21descendants
  • K140504Accucath BC Intravascular Catheter SystemVascular Pathways, Inc. · 2014 · 2 generations on7descendants
  • K153298AccuCath Intravascular CatheterC.R. Bard, Inc. · 2015 · 3 generations on5descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K013800Insyte, Angiocath, Insyte Autoguard, Angiocath Autoguard, Autoguard Pro…Becton Dickinson Infusion Therapy Systems, Inc.2001—
+1K081953Supercath 5Togo Medikit Co., Ltd.2009—
+1K093546Supercath 5 Model SP120-XX-XX, SP125-XX-XXTogo Medikit Co., Ltd.2009—
+1K110443BD Insyte Autoguard BCBecton, Dickinson & CO2011—
+2K140504Accucath BC Intravascular Catheter SystemVascular Pathways, Inc.2014—
+3K153298AccuCath Intravascular CatheterC.R. Bard, Inc.2015—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200920
201110
201230
201310
201420
201530
201630
201710
201810
201930
202040
202220
202310
202410
202550
202620
FIG. 1 — Lineage of K013800, 2001–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FOZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FOZ device

  1. #1 K243403 BD Nexiva™ Closed IV Catheter Systemscore 14.8 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (7)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Insyte™ IV Catheter
Named without a submission number
—
*—Angiocath™ IV Catheter
Named without a submission number
—
*—Insyte™ Autoguard™ IV Catheter
Named without a submission number
—
*—Angiocath™ Autoguard™ IV Catheter
Named without a submission number
—
*—Autoguard™ Pro IV Catheter
Named without a submission number
—
*—Intima™ IV Catheter
Named without a submission number
—
*—Saf-T-Intima™ IV Catheter
Named without a submission number
—

What descends from it? (35)

See all 35

7 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K081953Supercath 5Togo Medikit Co., Ltd.200928
K093546Supercath 5 Model SP120-XX-XX, SP125-XX-XXTogo Medikit Co., Ltd.200927
K110443BD Insyte Autoguard BCBecton, Dickinson & CO201121
K151698BD Angiocath IV Catheter, BD Insyte IV CatheterBecton Dickinson Infusion Therapy Systems, Inc.20152
K251422BD Saf-T-Intima™ Subcutaneous Catheter SystemBecton Dickinson Infusion Therapy Systems, Inc.20250
K210929MagiCath IIWoo Young Medical Co., Ltd.20220
K192230MF SafecathMedifirst Co., Ltd.20200

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K081953 (Togo Medikit Co., Ltd., 2009) has gone furthest, with 28 descendants of its own.

How does its category compare?

All FOZ devices

FOZ Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FOZ

11in 2025

2007: 62008: 92009: 92010: 32011: 62012: 132013: 42014: 92015: 102016: 92017: 92018: 12019: 82020: 102021: 42022: 82023: 92024: 62025: 112026 (partial year): 7
2007high 13 (2012) · low 1 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FOZ

91in 2025

2007: 159 days median2008: 103 days median2009: 30 days median2010: 28 days median2011: 132 days median2012: 122 days median2013: 104 days median2014: 99 days median2015: 107 days median2016: 63 days median2017: 51 days median2019: 140 days median2020: 191 days median2021: 242 days median2022: 183 days median2023: 129 days median2024: 190 days median2025: 91 days median2026 (partial year): 203 days median
2007high 242 (2021) · low 28 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FOZ

4in 2023

2007: 162009: 232010: 1152013: 22014: 42016: 3, 1 Class I2017: 222018: 42019: 32020: 32021: 12022: 4, 2 Class I2023: 4, 2 Class I2026 (partial year): 2
2007high 115 (2010) · low 0 (2008)2026

Class I (5 since 2007) Class II/III not classified

Adverse event reports per year · FOZ

5,110in 2025

2007: 3742008: 4222009: 5082010: 3702011: 7862012: 5602013: 6402014: 8152015: 7292016: 9252017: 1,9662018: 3,3052019: 4,3652020: 3,7972021: 4,6742022: 4,1332023: 4,4302024: 4,7722025: 5,110
2007high 5,110 (2025) · low 370 (2010)2025

MAUDE reports naming product code FOZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007615916374
200891030422
200993023508
2010328115370
201161320786
2012131220560
201341042640
20149994815
2015101070729
20169633 (1)925
2017951221,966
20181—43,305
2019814034,365
20201019133,797
2021424214,674
202281834 (2)4,133
202391294 (2)4,430
2024619004,772
2025119105,110
202672032—

What is it indicated for?

As provided in 21 CFR 880.5200, an intravascular catheter is a device that is inserted into the patient's vascular system for short term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravenously. These catheters may be used for any patient population with consideration given to adequacy of vascular anatomy and appropriateness of procedure.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K013800: Insyte, Angiocath, Insyte Autoguard, Angiocath Autoguard, Autoguard Pro, Intima, and Saf-T-Intima Intravascular Cathete.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K013800

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026